GlaxoSmithKline UK

Stockley Park West, Uxbridge, Middlesex, UB11 1BT
Telephone: +44 (0)800 221 441
Fax: +44 (0)208 990 4328
Medical Information e-mail: customercontactuk@gsk.com
Patient Information Leaflet last updated on the eMC: 31/10/2006
PIL Flolan 0.5mg Injection

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 31/10/2006 and displayed until Current
Reasons for adding or updating:
  • Change to date of revision
  • Change to side-effects
Updated on 13/04/2006 and displayed until 31/10/2006
Reasons for adding or updating:
  • Change to date of revision
  • Change of manufacturer
Updated on 18/02/2005 and displayed until 13/04/2006
Reasons for adding or updating:
  • Change to date of revision
  • Change to information about the device
  • Company name change or merger
Updated on 16/09/2002 and displayed until 18/02/2005
Reasons for adding or updating:
  • Update to PIL
Updated on 08/05/2002 and displayed until 16/09/2002
Reasons for adding or updating:
  • Update to PIL
Updated on 17/04/2001 and displayed until 08/05/2002
Reasons for adding or updating:
  • No reasons supplied

Active Ingredients/Generics

 
   epoprostenol sodium


© 2010 Datapharm Communications Ltd

Go to www.medicines.org.uk